Published in J Infect Dis on September 12, 2007
Critical pertussis illness in children: a multicenter prospective cohort study. Pediatr Crit Care Med (2013) 1.74
Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol (2010) 1.30
The role of Toll-like receptor-4 in pertussis vaccine-induced immunity. BMC Immunol (2008) 0.99
Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection. Infect Immun (2014) 0.92
Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis. Infect Immun (2010) 0.89
A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. Clin Vaccine Immunol (2009) 0.84
Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice. J Immunol (2011) 0.81
Resident microbiota affect Bordetella pertussis infectious dose and host specificity. J Infect Dis (2013) 0.78
Protective Role of Passively Transferred Maternal Cytokines against Bordetella pertussis Infection in Newborn Piglets. Infect Immun (2017) 0.77
Review of the neutrophil response to Bordetella pertussis infection. Pathog Dis (2015) 0.77
c-di-GMP enhances protective innate immunity in a murine model of pertussis. PLoS One (2014) 0.76
Complete Khoisan and Bantu genomes from southern Africa. Nature (2010) 9.06
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio (2014) 1.76
Role of antibodies in immunity to Bordetella infections. Infect Immun (2003) 1.71
Molecular signature of hypersaline adaptation: insights from genome and proteome composition of halophilic prokaryotes. Genome Biol (2008) 1.64
Modeling systems-level regulation of host immune responses. PLoS Comput Biol (2007) 1.56
Genomic and genetic analysis of Bordetella bacteriophages encoding reverse transcriptase-mediated tropism-switching cassettes. J Bacteriol (2004) 1.36
Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol Microbiol (2003) 1.35
Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest (2005) 1.32
Role of Bordetella O antigen in respiratory tract infection. Infect Immun (2003) 1.32
The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infect Immun (2006) 1.31
Comparative genomics of the classical Bordetella subspecies: the evolution and exchange of virulence-associated diversity amongst closely related pathogens. BMC Genomics (2012) 1.30
Evolution and emergence of Bordetella in humans. Trends Microbiol (2005) 1.25
Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect Immun (2005) 1.23
MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of mice: implications for Toll-like receptor signaling. Infect Immun (2005) 1.22
Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine (2010) 1.18
Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J Infect Dis (2004) 1.14
Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica. Infect Immun (2004) 1.13
Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun (2002) 1.13
Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence. J Immunol (2005) 1.13
Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3. Eur J Immunol (2004) 1.10
The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity. Infect Immun (2007) 1.09
The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4. J Immunol (2005) 1.08
pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection. Infect Immun (2004) 1.06
O antigen protects Bordetella parapertussis from complement. Infect Immun (2008) 1.04
Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. J Bacteriol (2008) 1.03
Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. PLoS One (2009) 1.01
Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. Infect Immun (2005) 1.00
Evolution of acute infections and the invasion-persistence trade-off. Am Nat (2009) 0.98
Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infect Immun (2009) 0.97
Acinetobacter skin carriage among US army soldiers deployed in Iraq. Infect Control Hosp Epidemiol (2007) 0.95
Association of bacterial colonization at the time of presentation to a combat support hospital in a combat zone with subsequent 30-day colonization or infection. Mil Med (2009) 0.93
Pertussis pathogenesis--what we know and what we don't know. J Infect Dis (2014) 0.92
Intracellular trafficking of Bordetella pertussis in human macrophages. Infect Immun (2010) 0.91
Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica. Microbes Infect (2007) 0.91
O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. PLoS One (2009) 0.90
Comparative role of immunoglobulin A in protective immunity against the Bordetellae. Infect Immun (2007) 0.90
Constraint-based network model of pathogen-immune system interactions. J R Soc Interface (2008) 0.89
IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response. J Immunol (2009) 0.89
Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. Proc Biol Sci (2010) 0.89
Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission. Infect Immun (2013) 0.89
Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis. Infect Immun (2010) 0.89
Lack of cross-protection against Bordetella holmesii after pertussis vaccination. Emerg Infect Dis (2012) 0.88
Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract. Infect Immun (2004) 0.87
The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis. Infect Immun (2009) 0.87
Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. PLoS One (2009) 0.87
A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo. PLoS One (2012) 0.85
CD11b is required for the resolution of inflammation induced by Bordetella bronchiseptica respiratory infection. Cell Microbiol (2006) 0.85
Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica. Infect Immun (2009) 0.84
Microarray and functional analysis of growth phase-dependent gene regulation in Bordetella bronchiseptica. Infect Immun (2009) 0.83
Bordetella pertussis acquires resistance to complement-mediated killing in vivo. Infect Immun (2003) 0.82
Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice. J Immunol (2011) 0.81
IEIIS Meeting minireview: Bordetella evolution: lipid A and Toll-like receptor 4. J Endotoxin Res (2007) 0.81
Phenotypic and genomic analysis of hypervirulent human-associated Bordetella bronchiseptica. BMC Microbiol (2012) 0.80
Identifying the age cohort responsible for transmission in a natural outbreak of Bordetella bronchiseptica. PLoS Pathog (2010) 0.79
Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen. Infect Immun (2012) 0.79
sigE facilitates the adaptation of Bordetella bronchiseptica to stress conditions and lethal infection in immunocompromised mice. BMC Microbiol (2012) 0.79
Resident microbiota affect Bordetella pertussis infectious dose and host specificity. J Infect Dis (2013) 0.78
Identification of a CO2 responsive regulon in Bordetella. PLoS One (2012) 0.77
Horizontally acquired divergent O-antigen contributes to escape from cross-immunity in the classical bordetellae. BMC Evol Biol (2013) 0.77
Antigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel o chain that is poorly immunogenic. J Biol Chem (2010) 0.76
Teaching ethical aptitude to graduate student researchers. Account Res (2013) 0.75